The Effect of the Timing of Postoperative Mobilisation After Locking Plate Osteosynthesis of Fractures of the Surgical Neck of the Humerus

Sponsor
University of Helsinki (Other)
Overall Status
Recruiting
CT.gov ID
NCT01524965
Collaborator
Finnish Institute for Health and Welfare (Other)
100
1
2
139
0.7

Study Details

Study Description

Brief Summary

Open reduction and locking plate osteosynthesis is a commonly used and well-accepted treatment for displaced fractures of the proximal humerus. The shoulders tend to end stiff despite intensive rehabilitation, limiting the function of the upper extremity and decreasing the quality of life. The accepted postoperative mobilisation protocol includes passive exercises until six weeks postoperatively and active range of motion exercises after that. There is good evidence that conservatively treated fractures of the same site heal better and faster if mobilised immediately. The study compares "standard mobilisation" versus "immmediate mobilisation" in a prospective, randomized, controlled trial in order to find the optimal time-frame for physiotherapy to produce best possible results. Outcome measures are assessed at specific time points after the operation and comparisons between groups are made to follow the rate of recovery and end results.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Immediate mobilisation after locking-plate osteosynthesis
  • Procedure: Standard mobilisation after locking plate osteosynthesis
  • Device: Osteosynthesis with a locking plate (Philos)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effect of the Timing of Postoperative Mobilisation After Locking Plate Osteosynthesis of Fractures of the Surgical Neck of the Humerus.
Study Start Date :
May 1, 2011
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Immediate mobilisation

Procedure: Immediate mobilisation after locking-plate osteosynthesis
Immediate passive range of motion exercises are begun postoperatively, after 3 weeks, active unloaded mobilisation begins after three weeks and active, loaded use is allowed 6 weeks postoperatively. Surgical procedure is open reduction of the fracture and internal fixation of the fracture using a locking plate using standard deltopectoral approach and AO principles in fracture management.

Device: Osteosynthesis with a locking plate (Philos)
Standard open reduction and internal fixation using a deltopectoral approach. Fracture fixation is done using a locking plate (Philos, Synthes) following the AO principles of fracture management.

Active Comparator: Standard mobilisation

Procedure: Standard mobilisation after locking plate osteosynthesis
Immediately postoperatively the arm is held in a sling, active mobilisation of healthy joints and pendel exercises are befun. Passive range of motion exercises of the shoulder are begun 3 weeks postoperatively. Active mobilisation begins after six weeks. Surgical procedure is open reduction of the fracture and internal fixation of the fracture using a locking plate using standard deltopectoral approach and AO principles in fracture management.

Device: Osteosynthesis with a locking plate (Philos)
Standard open reduction and internal fixation using a deltopectoral approach. Fracture fixation is done using a locking plate (Philos, Synthes) following the AO principles of fracture management.

Outcome Measures

Primary Outcome Measures

  1. Disablities of Arm, Hand and Shoulder [3 weeks]

    Validated patient-reported upper extremity function scale

  2. Disablities of Arm, Hand and Shoulder [6 weeks]

    Validated patient-reported upper extremity function scale

  3. Disablities of Arm, Hand and Shoulder [3 months]

    Validated patient-reported upper extremity function scale

  4. Disablities of Arm, Hand and Shoulder [6 months]

    Validated patient-reported upper extremity function scale

  5. Disablities of Arm, Hand and Shoulder [1 year]

    Validated patient-reported upper extremity function scale

  6. Disablities of Arm, Hand and Shoulder [2 years]

    Validated patient-reported upper extremity function scale

Secondary Outcome Measures

  1. Constant Score [3 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years]

    subjective and objective shoulder score

  2. Simple Shoulder Test (SST) [3 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years]

    another shoulder score

  3. Pain in rest and motion (2 different values) [3 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years]

    Numeric rating scale 0-10

  4. Subjective satisfaction [3 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years]

    Patient reported, Numeric Rating Scale 0-10

  5. Quality of Life [3 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years]

    Using the 15D instrument

  6. Complications [3 weeks, 6 weeks, 3 months, 6 months, 1 year, 2 years]

    Complications of surgery and postoperative phase

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 years or older

  • Surgery can be performed within 10 days of injury

  • A dislocated (>1cm or 35 degrees) AO 11-A2, -A3, -B1 or -B2 fracture of the surgical neck of the proximal humerus with a possible fracture of the Tuberculum Majus

Exclusion Criteria:
  • Glenohumeral dislocation

  • Fracture of the Tuberculum Minus

  • Open fracture

  • Additional fractures in the shoulder region

  • Other injuries requiring surgical treatment

  • Clinically significant injury of the brachial plexus or vasculature

  • Pathological fracture associated with cancer

  • History of a fracture of the clavicle, scapula or humerus, or history of a very significant disease or trauma of the shoulder region (hemiparesis, tumour, osteomyelitis, grave arthrosis etc)

  • Rheumatoid Arthritis in the shoulder requiring active treatment

  • Reduced co-operation or incapability for independent living (dementia, mental illness, drug- or alcohol abuse etc)

  • Unwillingness to accept some of the treatment options.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Töölö Hospital, Helsinki University Central Hospital Helsinki Finland 00029

Sponsors and Collaborators

  • University of Helsinki
  • Finnish Institute for Health and Welfare

Investigators

  • Principal Investigator: Tuomas Lähdeoja, MD, Helsinki University Central Hospital
  • Study Director: Mika Paavola, MD, PhD, Helsinki University Central Hospital
  • Study Director: Jarkko Pajarinen, MD, PhD, Helsinki University Central Hospital
  • Study Chair: Seppo Koskinen, Helsinki University Central Hospital
  • Study Chair: Antti Malmivaara, MD, PhD, Finnish Institute for Health and Welfare
  • Study Chair: Reijo Sund, MD, PhD, Finnish Institute for Health and Welfare

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tuomas Lahdeoja, MD, University of Helsinki
ClinicalTrials.gov Identifier:
NCT01524965
Other Study ID Numbers:
  • HUS-272/13/03/02/2010
First Posted:
Feb 2, 2012
Last Update Posted:
May 6, 2020
Last Verified:
May 1, 2020
Keywords provided by Tuomas Lahdeoja, MD, University of Helsinki
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2020